Compare CCAP & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCAP | USNA |
|---|---|---|
| Founded | 2015 | 1992 |
| Country | United States | United States |
| Employees | 250 | N/A |
| Industry | Finance: Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 418.9M | 397.1M |
| IPO Year | N/A | 1996 |
| Metric | CCAP | USNA |
|---|---|---|
| Price | $11.81 | $15.40 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $15.86 | N/A |
| AVG Volume (30 Days) | ★ 206.9K | 139.1K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | ★ 12.59% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.41 |
| Revenue | N/A | ★ $1,060,902,000.00 |
| Revenue This Year | N/A | $3.90 |
| Revenue Next Year | N/A | $6.21 |
| P/E Ratio | ★ $14.18 | $37.73 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.64 | $14.35 |
| 52 Week High | $16.04 | $32.32 |
| Indicator | CCAP | USNA |
|---|---|---|
| Relative Strength Index (RSI) | 61.86 | 26.36 |
| Support Level | $10.83 | N/A |
| Resistance Level | $13.57 | $21.78 |
| Average True Range (ATR) | 0.26 | 1.11 |
| MACD | 0.09 | -0.82 |
| Stochastic Oscillator | 98.26 | 5.84 |
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).